论文信息 - Streptozotocin, 1982–2022: Forty Years from the FDA’s Approval to Treat Pancreatic Neuroendocrine Tumors - 字舞流文

Streptozotocin, 1982–2022: Forty Years from the FDA’s Approval to Treat Pancreatic Neuroendocrine Tumors

M. Pavel | J. Capdevila | T. Halfdanarson | E. Grande | S. Tafuto | R. Salazar | S. Welin | M. Ducreux | V. Valenti | R. García Carbonero | V. Valentí